Who are the key players in North America Whole Exome Sequencing Market industry?

The top 5 key players in the North America Whole Exome Sequencing Market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Roche, and BGI Genomics. These companies excel in offering advanced exome sequencing platforms, innovative library preparation kits, robust bioinformatics tools, and comprehensive sequencing services across the healthcare and research sectors.

What is the North America Whole Exome Sequencing Market growth?

The North America Whole Exome Sequencing Market is experiencing steady growth, largely driven by increasing demand for precision medicine and genomics research. For instance, Illumina reported significant revenue gains in 2023 due to expanded collaborations with research institutions and clinical laboratories, fueling market expansion in the region.

Which segment accounted for the largest North America Whole Exome Sequencing Market share?

Diagnostics applications accounted for the largest market share in North America. Whole exome sequencing is widely adopted for identifying genetic variants responsible for rare diseases and cancers, enabling clinicians and researchers to deliver accurate diagnoses and personalized therapeutic strategies, leading to better patient outcomes and enhanced healthcare delivery.

What are the factors driving the North America Whole Exome Sequencing Market?

Recent drivers include technological advancements, decreasing sequencing costs, and greater adoption in clinical diagnostics. Companies like Thermo Fisher Scientific have introduced user-friendly exome sequencing solutions that streamline workflows, making sequencing more accessible to hospitals, academic institutions, and research centers, thereby accelerating market growth.

Which type accounted for the largest North America Whole Exome Sequencing Market share?

Sequencing-by-Synthesis (SBS) technology, primarily offered by players like Illumina, accounted for the largest market share. This technology is favored for its high accuracy, throughput, and scalability, making it the preferred choice for clinical and research applications that require comprehensive exome analysis across diverse sample types.

Home Healthcare

North America Whole Exome Sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Whole Exome Sequencing Market: by Type (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Application (Diagnostics, Drug Discovery, Personalized Medicine, Agriculture & Animal Research, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors, Others), Technology (Next-Generation Sequencing, Sanger Sequencing, Nanopore Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20482

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2170
Regions	United States, Canada, Mexico
Segments	Sequencing by Synthesis, Ion Semiconductor Sequencing, Single Molecule Real Time Sequencing, Nanopore Sequencing, Pyrosequencing, Others; Diagnostics, Drug Discovery, Personalized Medicine, Agriculture & Animal Research, Biomarker Discovery, Others
Players	Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Roche Holding AG, QIAGEN N.V., Eurofins Scientific, BGI Genomics Co. Ltd., Bio-Rad Laboratories Inc., GeneDx, Pacific Biosciences of California Inc., Macrogen Inc., PerkinElmer Inc., GENEWIZ (Part of Brooks Automation), Personalis Inc., Other Key Players

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	2170
Regions	United States, Canada, Mexico
Segments	Sequencing by Synthesis, Ion Semiconductor Sequencing, Single Molecule Real Time Sequencing, Nanopore Sequencing, Pyrosequencing, Others; Diagnostics, Drug Discovery, Personalized Medicine, Agriculture & Animal Research, Biomarker Discovery, Others
Players	Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Roche Holding AG, QIAGEN N.V., Eurofins Scientific, BGI Genomics Co. Ltd., Bio-Rad Laboratories Inc., GeneDx, Pacific Biosciences of California Inc., Macrogen Inc., PerkinElmer Inc., GENEWIZ (Part of Brooks Automation), Personalis Inc., Other Key Players